Lutathera (lutetium Lu 177 dotatate) - Novartis
Time Dependent Red Marrow-to-Blood Activity Concentration Ratios Challenge Blood-Based Dosimetry in [ 177 Lu]Lu-DOTA-TATE Therapy (EANM 2026) - Sep 29, 2026 - Abstract #OP-680; Pres time: Oct 20, 2026; 03:00 PM - 04:30 PM; Location: Hall B; "RMBLR values were substantially greater than 1 in the vast majority of measurements and showed pronounced time dependence. These findings indicate that the assumption of equivalence between blood and red marrow activity concentrations in blood-based dosimetry is not valid for [177Lu]Lu-DOTA-TATE therapy and is likely to result in systematic underestimation of RM absorbed dose. The observed temporal increase in RMBLR further challenges the use of a fixed ratio in blood-based dosimetry approaches." 
Neuroendocrine Tumor • Solid Tumor
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
T. Monserrat Fuertes 1; J. Hemmingsson 2; P. Mínguez Gabiña 3; A. Álvarez Amigo 1; C. Díaz Aviñó 1; G. V. P. Prado 1; D. P. Suárez 1; M. A. Peinado Montes 1; P. Bernhardt 2, 4
 
Sep 29, 2026
 
Prev Next